Navigation Links
The Polymicrobial Nature Of Diabetic Foot Infections

Foot infections are a major cause for hospitalization of patients with diabetes. Foot ulceration and infection are risks for subsequent amputation. Ischemia, neuropathy, and infection in patients with diabetes combine to produce tissue necrosis and ulcers//. Diabetic foot infections are generally polymicrobial in nature.

Early recognition of lesions and prompt initiation of appropriate antibiotic therapy, as well as aggressive surgical debridement of necrotic soft tissue and bone, and a modification of host factors (i.e., hyperglycemia, concomitant arterial insufficiency) are important for successful outcome.

A recent study, published in the May-June issue of Journal of Diabetes and its Complications, evaluated the bacteriology of diabetic foot ulcers at the Adan teaching hospital, Ministry of Health in Kuwait, Kuwait. The relative frequency of bacterial isolates cultured from community-acquired foot infections that were not exposed to antimicrobial agents for 30 days were studied. In addition, the bacterial comparative in vitro susceptibility to the commonly used antibacterial agents was assessed.

During the study, the infected wounds of 86 consecutive diabetic patients were cultured. The patients did not receive antimicrobial therapy 30 days prior to taking the cultures. The specimen was cultured using aerobic and anaerobic microbiological techniques. Isolates were tested for susceptibility to commonly used antimicrobial therapy. S. aureus and P. aeruginosa were found to be the most common causes of diabetic foot infections.

Anaerobic organisms, majority of them were bacteroids, are still a common cause for infection, although the prevalence is less. These wounds may require use of combined antimicrobial therapy for initial management. Among the gram-negative enteric bacilli, P. mirabilis was the most frequently seen, followed by Escherichia coli and Klebseilla. Imipenem, meropenem, and cefepime were th e most effective agents against gram-negative organisms. Vancomycin was the most effective against gram-positive organisms.

The authors suggest that while choosing an antimicrobial for the treatment of diabetic foot infections, one should consider the spectrum of causative organisms, their resistant patterns, efficacy, and safety. Awareness of the causative organisms in diabetic foot infections and their antimicrobial susceptibility pattern is essential for the institution of antimicrobial therapy.

Related medicine news :

1. Reaction To ADHD Medication May Be Genetic By Nature
2. Risk Of Stroke May Be Genetic By Nature
3. Nature Cures The Best, Say WIC Clinic Clients
4. Nature’s fury leaves permanent scar
5. Nature’s Bounty ,Seaweed, Becomes A Blessing For Diabetes Patient
6. Morning Sickness - Natures Way Of Ensuring Healthy Diet In Pregnancy
7. Morning Sickness: Natures Warning Signal To Would –Be- Mom
8. Where Burnt Out Executives De-stress in Natures Lap
9. Nature Behind Most New Drugs
10. New Drug in Diabetic Neuropathy
11. Cinnamon May Help Diabetics
Post Your Comments:

(Date:10/12/2015)... ... October 13, 2015 , ... Career Step, an online ... of its new Professional Medical Coding and Billing with Applied PCS career training ... ICD-10-PCS code sets, earn the Certified Professional Coder (CPC) and Certified Coding Associate ...
(Date:10/12/2015)... , ... October 12, 2015 , ... ... August 19, 2015, high school aged female athletes, particularly in the area of ... repetitive motion and mechanical overuse injuries than male peers in the same age ...
(Date:10/12/2015)... Los Angeles, CA (PRWEB) , ... October 12, 2015 , ... ... 7th, the Fire Chief for the city of San Antonio, Texas recommended that any ... retrofitted to incorporate these important safety systems going forward. The article explains that it ...
(Date:10/12/2015)... ... October 12, 2015 , ... AcousticSheep LLC, ... Cleveland Clinic in honor of Breast Cancer Awareness Month. During the month ... will donate a SleepPhones® Classic product to a breast cancer patient at the ...
(Date:10/12/2015)... (PRWEB) , ... October 12, 2015 , ... On July ... MN. Their mission: To paddle the entire 2,320-miles of river to the Gulf of ... halfway done with the monumental journey, with two months remaining for a November 22nd ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... October 12, 2015 ... to grow at 7.2% CAGR, microscopy market ... rising focus on nanotechnology, technological advancements, and ... report available with ... . --> Complete report on ...
(Date:10/12/2015)...   Royal Philips (NYSE: PHG, AEX: PHIA), ... a collaboration with Genomic Health , Inc. (NASDAQ: ... diagnostic tests, to leverage Philips digital pathology tools in ... testing processes.    --> ... samples and plays a crucial role in the diagnosis ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: ... District of Delaware granted the Company,s ... Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to market ... (buprenorphine and naloxone) Sublingual Film (CIII) in the ... --> Since August 2013, Indivior has received Paragraph IV ...
Breaking Medicine Technology: